Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 20, 2020 - Issue 5
Submit an article Journal homepage
102
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics

Kyung-Bok SonCollege of Pharmacy, Ewha Womans University, Seoul, South KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6343-5808View further author information
ORCID Icon
Pages 541-548 | Received 07 May 2019, Accepted 03 Sep 2019, Published online: 10 Sep 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kyung-Bok Son. (2022) Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures. Expert Review of Pharmacoeconomics & Outcomes Research 22:5, pages 815-822.
Read now

Articles from other publishers (8)

Kyung-Bok Son. (2023) Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?. Frontiers in Public Health 11.
Crossref
Lu Liu. (2022) Deregulation on branded and generic drugs price and its effect: a study of Chinese pharmaceutical market. International Journal of Health Governance 28:1, pages 17-30.
Crossref
Kyung-Bok Son. (2022) Patenting and patent challenges in South Korea after introducing a patent linkage system. Globalization and Health 18:1.
Crossref
Kyung-Bok Son & Eui-Kyung Lee. (2022) Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study. Family Practice 39:5, pages 791-798.
Crossref
Kyung-Bok Son. (2022) Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?. Frontiers in Public Health 10.
Crossref
Kyung-Bok Son, Nahye Choi, Boram Lee, Joonsoo Byun, Dong-Wook Yang & Tae-Jin Lee. (2021) Patent challenges and factors associated with successful patent challengers under the patent linkage system: recent evidence from South Korea after the Korea United States free trade agreement. Globalization and Health 17:1.
Crossref
Kyung-Bok Son. (2020) Is greater generic competition also linked to lower drug prices in South Korea?. Health Economics Review 10:1.
Crossref
Jeewon Park, SeungJin Bae, Tae-Jin Lee & Kyung-Bok Son. (2020) Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate. Frontiers in Pharmacology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.